Hypoglycemic syndrome in hepatic epithelioid hemangioendothelioma, successful treatment — liver transplantation from a living related donor

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Hypoglycemic syndrome occurs not only in endocrine diseases but can complicate the course of many somatic diseases and tumors of pancreatic and extra-pancreatic localization. Development of hypoglycemia in liver tumors is associated with a decrease in the volume of functioning liver tissue, increased consumption, and utilization of glucose by the tumor tissue, inhibition of gluconeogenesis and glycogenolysis, and secretion of insulin-like peptides. Hypoglycemia in liver tumors is rarely the first symptom of the disease and usually occurs in patients with large tumor sizes and symptoms of tumor intoxication. Epithelioid hemangiendothelioma of the liver is the primary malignant neoplasm from the group of mesenchymal tumors, it occurs less than in 1% of cases of all malignant neoplasms of the liver. The clinical course of epithelioid hemangiendothelioma of the liver is highly variable. There are slowly and rapidly progressing variants. The diagnosis is based on the results of histological and immunohistochemical examination of the postoperative material. In the literature there is no description of hypoglycemia in epithelioid hemangiendothelioma. We report a patient with severe hypoglycemic syndrome, which was due to an epithelioid hemangioendothelioma of the liver. Pharmacological treatment of hypoglycemia was ineffective. The presence of massive bilobar tumor made it impossible to use a liver resection. Hepatectomy with living related liver transplantation was life-saving procedure and made it possible to eliminate hypoglycemia.

Full Text

Restricted Access

About the authors

Irina A Bondar

Novosibirsk State Medical University

Email: bondaria@oblmed.nsk.ru
SPIN-code: 6633-8947
MD, PhD, Professor 52, Krasny prospect, Novosibirsk, 630091

Ludmila I Chesnochenko

Novosibirsk State Medical University

Email: z111777@yandex.ru
SPIN-code: 6633-8947
MD, PhD 52, Krasny prospect, Novosibirsk, 630091

Olesia Yu Shabelnikova

Novosibirsk State Medical University; Novosibirsk State Regional Clinical Hospital

Email: oushab@ngs.ru
SPIN-code: 5941-4815
MD, PhD 52, Krasniy prospect, Novosibirsk, 630091; 130, Nemirovicha-Danchenko str., 630087, Novosibirsk

Ivan A Porshennikov

Novosibirsk State Medical University; Novosibirsk State Regional Clinical Hospital

Email: porshennikov@mail.ru
SPIN-code: 7291-7988
MD, PhD 52, Krasniy prospect, Novosibirsk, 630091; 130, Nemirovicha-Danchenko str., 630087, Novosibirsk

References

  1. Saigal S, Nandeesh HP, Malhotra V, Sarin SK. A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection. Am J Gastroenterol. 1998;93(8):1380-1381. doi: https://doi.org/10.1111/j.1572-0241.1998.427_h.x
  2. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-538. doi: https://doi.org/10.1016/j.jhep.2006.05.013
  3. Daughaday WH. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I. J Clin Endocrinol Metab. 2007;92(5):1616. doi: https://doi.org/10.1210/jc.2007-0378
  4. Morbois-Trabut L, Maillot F, De Widerspach-Thor A, et al. «Big IGF-II»-induced hypoglycemia secondary to gastric adenocarcinoma. Diabetes Metab. 2004;30(3):276-279. doi: https://doi.org/10.1016/S1262-3636(07)70119-2
  5. Yeung RT. Hypoglycaemia in hepatocellular carcinoma: a review. Hong Kong Med J. 1997;3(3):297-301.
  6. Grotz TE, Nagorney D, Donohue J, et al. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB (Oxford). 2010;12(8):546-553. doi: https://doi.org/10.1111/j.1477-2574.2010.00213.x
  7. Hu HJ, Jin YW, Jing QY, et al. Hepatic epithelioid hemangioendothelioma: Dilemma and challenges in the preoperative diagnosis. World J Gastroenterol. 2016;22(41):9247-9250. doi: https://doi.org/10.3748/wjg.v22.i41.9247
  8. D’Annibale M, Piovanello P, Carlini P, et al. Epithelioid hemangioendothelioma of the liver: case report and review of the literature. Transplant Proc. 2002;34(4):1248-1251. doi: https://doi.org/10.1016/S0041-1345(02)02751-3
  9. Schiff ER, Maddrey WC, Rajender K. Schiff’s Diseases of the Liver. 8th ed. New York: Lippincott-Raven; 1999.
  10. Sorlini M, Benini F, Cravarezza P, Romanelli G. Hypoglycemia, an atypical early sign of hepatocellular carcinoma. J Gastrointest Cancer. 2010;41(3):209-211. doi: https://doi.org/10.1007/s12029-010-9137-0
  11. Benn JJ, Firth RG, Sonksen PH. Metabolic effects of an insulin-like factor causing hypoglycaemia in a patient with a haemangiopericytoma. Clin Endocrinol (Oxf). 1990;32(6):769-780. doi: https://doi.org/10.1111/j.1365-2265.1990.tb00924.x
  12. Sharma M, Reddy DN, Kiat TC. Refractory Hypoglycemia Presenting as First Manifestation of Advanced Hepatocellular Carcinoma. ACG Case Rep J. 2014;2(1):50-52. doi: https://doi.org/10.14309/crj.2014.82
  13. Tsai CY, Chou SC, Liu HT, et al. Persistent hypoglycemia as an early, atypical presentation of hepatocellular carcinoma: A case report and systematic review of the literature. Oncol Lett. 2014;8(4):1810-1814. doi: https://doi.org/10.3892/ol.2014.2365
  14. Daughaday WH. Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I. J Clin Endocrinol Metab. 2007;92(5):1616. doi: https://doi.org/10.1210/jc.2007-0378
  15. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer. 1992;65(3):311-320.
  16. Thipaporn T, Bubpha P, Varaphon V. Hepatocellular carcinoma with persistent hypoglycemia: successful treatment with corticosteroid and frequent high carbohydrate intake. J Med Assoc Thai. 2005;88(12):1941-1946.
  17. Hoff AO, Vassilopoulou-Sellin R. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia. Cancer. 1998;82(8):1585-1592. doi: https://doi.org/10.1002/(SICI)1097-0142(19980415)82:8< 1585::AID-CNCR22>3.0.CO;2-#
  18. Nikeghbalian S, Bananzadeh A, Yarmohammadi H. Hypoglycemia, the first presenting sign of hepatocellular carcinoma. Saudi Med J. 2006;27(3):387-388.
  19. Le Roith D. Tumor-induced hypoglycemia. N Engl J Med. 1999; 341(10):757-758. doi: https://doi.org/10.1056/NEJM199909023411011
  20. Yonei Y, Tanaka M, Ozawa Y, et al. Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors. Liver. 1992;12(2):90-93. doi: https://doi.org/10.1111/j.1600-0676.1992.tb00563.x

Statistics

Views

Abstract: 13

PlumX


Copyright (c) 2020 Bondar I.A., Chesnochenko L.I., Shabelnikova O.Y., Porshennikov I.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies